Implicity ILR ECG Analyzer
Contact vendor for pricing information.
Regulatory Status Disclosed
Overview
The Implicity ILR ECG Analyzer is an AI-powered, cloud-based digital medical device designed to analyze electrocardiogram (ECG) data transmitted from implantable loop recorders (ILRs). The software applies advanced signal processing and machine learning algorithms to heart rhythm data to improve the accuracy of irregular heartbeat detection and reduce the volume of false-positive alerts.
This tool is specifically designed for:
- Electrophysiologists and cardiologists managing patients with implantable cardiac monitors.
- Clinical care teams, including cardiac nurses and technicians, who oversee remote monitoring workflows.
- Cardiac remote monitoring clinics and independent diagnostic testing facilities (IDTFs).
The analyzer integrates directly into Implicity’s unified cardiac remote monitoring platform. In a typical clinical workflow, data transmitted from compatible Medtronic ILR models (such as Reveal LINQ, Reveal XT, and Reveal DX) is automatically processed in the cloud. The algorithm filters out non-actionable events and prioritizes true arrhythmic episodes, allowing clinical teams to focus their review on clinically relevant data without manual pre-filtering.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-Powered ILR ECG Analyzer: Reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity.
- Unified Device Data: Centralizes and standardizes all cardiac implantable device data.
- AI-Driven Alert Management: Filters alerts with FDA-cleared algorithms, highlighting clinically relevant events.
- Smart Workflow Automation: Provides real-time access and automates billing workflows and reporting.
- InLink: Streamlines in-clinic data workflow.
- Patient Connectivity Management: Automated SMS to reconnect 28% of disconnected patients within two days.
- AF Alert Management: Detects clinically relevant events, leading to an 85% decrease in unnecessary AF alerts.
- Dynamic Billing Engine: Achieves 90%+ billing compliance with optimized scheduling and auto-generated reports.
- SignalHF Predictive AI: FDA-cleared AI to predict hospitalizations for heart failure patients.
- EHR Integration Capabilities: Comprehensive API and integration framework for seamless data exchange.
Use Cases
- Improving arrhythmia detection for electrophysiology teams
- Reducing false alerts and alarm fatigue for care teams
- Automating billing and reporting for administrative and billing teams
- Ensuring data security and compliance for IT teams
- Optimizing remote monitoring of CIEDs and ILRs
- Predicting hospitalizations for heart failure patients
What Physicians Need to Know
ECG/EKG Analysis Capability
The ILR ECG Analyzer is a software medical device that analyzes ECG signals from Insertable Cardiac Monitors (ICMs) to confirm the presence or absence of arrhythmias. It processes ECG data to detect asystole, bradycardia, atrial tachycardia/fibrillation, ventricular tachycardia, normal rhythm, and artifacts. The device is intended for use in adult patients (18 years and older) with compatible ICMs for diagnosing or monitoring cardiac arrhythmias.
Arrhythmia Detection Accuracy
The ILR ECG Analyzer utilizes AI to reduce false positives in ECG recordings from ICMs. Studies have shown it can reduce false-positive episodes by up to 79% while maintaining high sensitivity (99% in some studies, >98% in others) for detecting clinically meaningful events. It has a reported sensitivity of 98.64% and a false positive rate of 24.03%. The algorithm has demonstrated a 99.0% Negative Predictive Value (NPV) and a 78.2% Positive Predictive Value (PPV) in real-world performance. The latest version of the algorithm can reduce false positives by up to 76% across all major device manufacturers.
Cardiac Monitoring Integration
The ILR ECG Analyzer is designed to be electronically interfaced with compatible remote monitoring platforms. It receives ECG data from these platforms and transmits analysis results back for healthcare professionals to view. The platform aggregates and standardizes data from various cardiac implantable electronic device (CIED) manufacturers into a unified interface. The latest version of the ILR ECG Analyzer can analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic. Previously, it primarily supported ECG data from Medtronic ICMs (Medtronic LNQ11, REVEAL XT 9529, REVEAL DX 9528).
Real-Time Alert Capability
The ILR ECG Analyzer acts as a secondary filter for alerts generated by ICMs, aiming to reduce the burden of false-positive alerts on clinicians. By filtering out non-actionable alerts, it helps care teams prioritize events that truly require clinical attention.
Physician Tip
The ILR ECG Analyzer is an advisory tool and its interpretation results are not intended to be the sole means of diagnosis. Physicians should use the analysis in conjunction with their clinical knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. The tool aims to improve the efficiency of remote monitoring by reducing false positives, allowing healthcare professionals to focus on clinically meaningful cardiac arrhythmia events.
The Implicity platform, which includes the ILR ECG Analyzer, is designed to integrate with remote monitoring platforms from various cardiac device manufacturers. It offers a universal platform to consolidate data from major device manufacturers. Implicity also markets a bidirectional EHR/EMR integration.
Details
| Category | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Contact vendor for pricing information. |
| Deployment | Cloud-based / SaaS |
| API Available | Unknown |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
What the Web Says
The Implicity ILR ECG Analyzer is an AI-powered software designed to reduce false-positive alerts generated by Implantable Loop Recorders (ILRs) and Implantable Cardiac Monitors (ICMs). It acts as a secondary filter, analyzing ECG data to improve the accuracy of arrhythmia detection and reduce the workload for healthcare professionals. The analyzer has received FDA clearance, with its latest version capable of analyzing data from devices across all major manufacturers.
Overall: PositiveStrengths
- Significantly reduces false-positive alerts, with studies showing reductions of up to 79% for Medtronic ILRs and up to 76% across various ICMs.
- Maintains high sensitivity for detecting clinically meaningful arrhythmias (99% for Medtronic ILRs, 98.3% in AI-equipped devices, and 94.3% in non-AI models).
- Boosts medical staff productivity by allowing them to focus on real and actionable cardiac events.
- Compatible with various Medtronic ILR models (Reveal LINQ, Reveal XT, Reveal DX) and, with its latest version, across all major ICM manufacturers (Abbott, Biotronik, Boston Scientific, and Medtronic).
- Provides a standardized, manufacturer-agnostic layer for data analysis, mitigating noise and delivering consistency across patient populations.
- Aims to improve patient outcomes by enabling earlier detection of true arrhythmias.
Limitations
- No specific cons were identified in the provided search results regarding the Implicity ILR ECG Analyzer itself. Reviews for general ILR devices on Reddit mention potential pain during implantation and recovery, and concerns about infrequent monitoring of data by doctors' offices.
Based on reviews from: capterra.com, implicity.com, innovationsincrm.com, prnewswire.com, mdpi.com, nih.gov, dicardiology.com, aihealthindex.io, google.com, hcplive.com, mpo-mag.com, mddionline.com, globenewswire.com, reddit.com, cardiacrhythmnews.com, fda.gov, elion.health
Last updated: 2026-10-30
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Implicity ILR ECG Analyzer
Press & Coverage
GlobeNewswire
Implicity's Next-Generation ILR ECG Analyzer Earns FDA Clearance
Implicity has received 510(k) clearance from the FDA for its next-generation ILR ECG Analyzer, a cloud-based AI software designed to reduce false-positive alerts from implantable cardiac monitors across all major manufacturers by up to 76%. This marks the company's third FDA clearance and aims to improve workflow efficiency for healthcare providers.
2026-07
Pluang
Implicity's AI ECG Analyzer gets FDA clearance, cutting false alerts from cardiac monitors by 76%
Implicity's next-generation ILR ECG Analyzer, an AI-powered cloud software, has received FDA clearance for its ability to reduce false-positive alerts from implantable cardiac monitors by up to 76% while maintaining high sensitivity for true cardiac events. The software is compatible with devices from all major manufacturers and is expected to be commercially available in the U.S. soon.
2026-07
HCPLive
FDA-Cleared AI-Assisted ECG Analyzer Algorithm Reduces False Positives in ICMs
On July 28, 2026, the FDA granted 510(k) clearance to Implicity's ILR ECG Analyzer, which acts as a second layer for residual alerts from implantable cardiac monitors (ICMs), significantly reducing false positives while maintaining high sensitivity for clinically meaningful events. The algorithm can analyze data from all major device manufacturers.
2026-08
Medical Product Outsourcing (MPO)
Implicity's Next-Gen ILR ECG Analyzer Cleared by FDA
Implicity's next-generation ILR ECG Analyzer has received 510(k) clearance from the FDA, marking the company's third FDA clearance. This cloud-based AI software acts as a secondary filter for alerts from implantable cardiac monitors, reducing false positives by up to 76% across major manufacturers.
2026-10
implicity.com
Implicity Announces New Study Results for its AI-Powered ILR ECG Analyzer
A study evaluated Implicity's cloud-based AI algorithm (V2) for analyzing ICM transmissions, demonstrating high sensitivity (98.3% for AI-equipped devices and 94.3% for non-AI models) for detecting clinically meaningful arrhythmias while filtering a substantial proportion of non-actionable alerts.
2026-04
PR Newswire
Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders
Implicity announced FDA clearance for its AI-powered ILR ECG Analyzer, an algorithm that analyzes ECG data from Implantable Loop Recorders (ILRs). This breakthrough innovation aims to improve arrhythmia detection and reduce the time electrophysiologists spend reviewing non-actionable events.
2021-12
MD+DI Online
Implicity's AI-Powered ILR ECG Analyzer for Implantable Loop Recorders Receives FDA Clearance
Implicity received FDA clearance for its AI-powered ILR ECG Analyzer, an algorithm designed to analyze ECG data from Implantable Loop Recorders (ILRs) and reduce false positives. The initial version of the analyzer was compatible with Medtronic ILRs.
2022-02
implicity.com
ILR ECG Analyzer
The ILR ECG Analyzer is a software medical device that uses AI to classify ECGs from Medtronic ILRs, reducing false positives by 79% while maintaining 99% sensitivity. It is an FDA-cleared Class II medical device and CE marked Class I medical device.
2021-06
Videos
Product demos, reviews, and walkthroughs for Implicity ILR ECG Analyzer.
Remote Cardiac Monitoring with Dr. Jay Ganji at Piedmont Cardiovascular
Implicity - Smart Remote Monitoring
![[Heart Rhythm] Management of CIEDs with New Remote Monitoring Features: from Standard of Care to AI](https://i.ytimg.com/vi/KKzKUo3YBYQ/mqdefault.jpg)
![[Heart Rhythm] Reducing workload and improving patient care with AI-powered CRM](https://i.ytimg.com/vi/qXLhvXUXVI4/mqdefault.jpg)
Frequently Asked Questions
The Implicity ILR ECG Analyzer utilizes AI to significantly reduce false positive alerts generated by implantable cardiac monitors (ICMs), including ILRs. This AI-powered analysis acts as a second layer of filtering on top of manufacturer algorithms, helping clinicians focus on clinically meaningful events and reducing the workload associated with reviewing non-actionable alerts.
The Implicity ILR ECG Analyzer is an FDA-cleared Class II medical device and is CE marked as a Class I medical device under the Medical Device Directive 93/42/EEC. It has received multiple FDA clearances, with the latest allowing it to analyze data from ICMs across all major device manufacturers.
The Implicity ILR ECG Analyzer is intended for adjunctive use and its interpretation results are not meant to be the sole means of diagnosis. It should be used by qualified healthcare professionals in conjunction with their clinical knowledge, patient background, history, symptoms, and other diagnostic information. Additionally, it is not for use in life-supporting or life-sustaining systems or as an ECG monitor and alarm device.
Implicity's platform adheres to strict regulatory standards, including HIPAA and GDPR, to ensure patient data integrity and confidentiality. It also holds ISO 27001 and HDS certifications, demonstrating a robust framework for data security and compliance.
Alternatives to ILRs for long-term cardiac monitoring include extended patch monitors, mobile cardiac telemetry (MCOT), and AI-driven remote patient monitoring platforms. While these options offer varying durations and capabilities, Implicity's platform differentiates itself by providing a universal, AI-driven solution that aggregates and standardizes data from all major CIED and ILR manufacturers, aiming to reduce false positives and streamline workflows.
Yes, the Implicity platform offers comprehensive API and integration frameworks for seamless data exchange with core hospital systems, including EHR integration capabilities.
Compare Implicity ILR ECG Analyzer
VS
BrightHeart View Classifier vs Implicity ILR ECG Analyzer
BrightHeart View Classifier focuses on AI-powered guidance and analysis for *prenatal ultrasound exams* to detect congenital heart defects and ensure exam completeness. Implicity ILR ECG Analyzer, on the…
VS
Implicity ILR ECG Analyzer vs PMcardio
Tool A, Implicity ILR ECG Analyzer, focuses on remote monitoring of cardiac implantable devices and ILRs, aiming to reduce false positives and streamline workflows for existing device data.…
VS
Implicity ILR ECG Analyzer vs EchoNext
These tools are adjacent in their application of AI to cardiology but serve different primary functions. Implicity ILR ECG Analyzer focuses on optimizing remote monitoring and management of…
VS
Implicity ILR ECG Analyzer vs Cardiomo
These tools are adjacent in their comparability, both focusing on AI-powered remote cardiac monitoring. Implicity ILR ECG Analyzer specializes in optimizing workflows and reducing false positives for existing…
Suggest an Edit → | Report an issue
| Last Verified: 2026-04-18 | First Added: 2026-04-18
Investors who backed Implicity ILR ECG Analyzer
Funded through the company that built this tool.
